Mov Disord Vol 37, Suppl 2 Archives - Page 32 of 153 - MDS Abstracts

2022 International Congress
Frequency of depression and predictors of mood change among caregivers of Parkinson’s disease patients
C. Iñiguez Alvarado, D. Santos García, T. Deus Fonticoba, C. Cores, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miró, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldente, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. ávila Rivera, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. García-Soto, C. Borrué, B. Solano Vila, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez Estrada, M. Seijo, J. Rúiz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González Ardura, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martinez-Martin, P. Mir (A Coruña, Spain)
Objective: The aim of the present study was to analyze the frequency of depression in a cohort of caregivers of patients with Parkinson ́s disease…
2022 International Congress
Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes
G. Carey, R. Lopes, A. Moonen, A. Mulders, J. de Jong, G. Kuchcinski, L. Defebvre, M. Kuijf, K. Dujardin, A. Leentjens (Lille, France)
Objective: To identify changes in functional connectivity in the brain after cognitive behavioral therapy (CBT) for anxiety in patients with Parkinson's disease (PD). Background: CBT…
2022 International Congress
Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease
E. Alushaj, D. Hemachandra, N. Handfield-Jones, A. Kuurstra, R. Menon, A. Owen, A. Khan, P. Macdonald (London, Canada)
Objective: To identify an imaging diagnostic biomarker of PD for use in clinics by applying structural magnetic resonance imaging (MRI) techniques. Background: The midbrain dopaminergic…
2022 International Congress
Alprazolam reduces freezing of gait and improves freezing-related gait measures
A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)
Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
2022 International Congress
Belly Dance Dyskinesia, a manifestation of B12 deficiency and hyperhomocysteinuria in MTHFR gene mutation. Videographic record of a case.
D. López Domínguez, B. Solano Vila, A. Cots Foraster (Girona, Spain)
Objective: We present a case of probable Belly Dance Dyskinesia (BDD) secondary to vitamin B12 deficiency. Background: BDD is a rare movement disorder (considered a…
2022 International Congress
Anosognosia in HD: Comparison of Self-report and Caregiver Ratings with Objective Performance Measures
SB. Hughes, A. Smirnova, A. Hall, C. Snell, B. Wright, PE. Gilbert, J. Corey-Bloom (San Diego, USA)
Objective: Objective: To compare patient and caregiver report of cognitive, motoric, and psychiatric symptoms versus objective performance measures in patients with Huntington’s disease (HD). Background:…
2022 International Congress
Design of the Remote Optimization Adjustment and Measurement for Deep Brain Stimulation (ROAM-DBS) Randomized Controlled Trial Using Decentralized Patient Monitoring
T. Tomlinson, A. Gharabaghi, S. Groppa, L. Luo, H. Lu, M. Feldman, C. Luca, V. Marshall, A. Merola, L. Muñoz-Delgado, A. Schnitzler, L. Verhagen, B. Walter, C. Wu, S. Zauber, L. Zhang, B. Cheeran (Plano, USA)
Objective: To describe the design of the ROAM-DBS trial which measures outcomes of remote programming using remote monitoring. Background: A third of Parkinson’s Disease (PD)…
2022 International Congress
Gray matter volumetry, cortical thickness and cognitive performance in treated Parkinson’s disease with REM sleep behavior disorder symptomatology
J. Oltra, A. Campabadal, C. Uribe, J. Pardo, MJ. Marti, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)
Objective: To explore MRI subcortical and cortical gray matter measures, as well as cognitive performance, in treated PD patients with REM sleep behavior disorder (RBD)…
2022 International Congress
Deep behavioural analysis of zebrafish models of Parkinson’s disease
TM. Tzotzolaki, J. Garcia Fernandez, F. de Santis, J. Terriente (Barcelona, Spain)
Objective: The objective is to characterise parkinsonian phenotypes in genetic and pharmacological models of Parkinson's disease (PD) using zebrafish. Background: Parkinson’s disease (PD) is a…
2022 International Congress
The changes in activities of daily livings after deep brain stimulation in Parkinson’s disease
T. Yamamoto, M. Suzuki, S. Hirano, Y. Yamanaka, A. Sugiyama, N. Araki, Y. Higuchi, S. Kuwabara (Chiba, Japan)
Objective: We aimed to clarify long-term changes in activities of daily living in patients with Parkinson's disease (PD) who underwent deep brain stimulation (DBS). Background:…